Stocks
Pliant Therapeutics, Inc.PLRX
NASDAQHealthcareBiotechnology$0.90
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing small molecule therapies for fibrotic diseases, including lead candidate bexotegrast for idiopathic pulmonary fibrosis. Its pipeline targets integrin receptors involved in tissue scarring, with ongoing Phase 2b trials that investors monitor for efficacy and safety data.
52W Range: $0.88-$1.95
Congressional Interest in Pliant Therapeutics, Inc. (PLRX)
No congressional trades have been disclosed for Pliant Therapeutics, Inc. (PLRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PLRX?
No congressional trades found for this stock.